G-Protein β3 Subunit 825 CC Genotype Is Associated with Unexplained (Functional) Dyspepsia

Gastroenterology

Volumn 126, Issue 4, 2004, Pages 971-979

  Holtmann, Gerald ^a   Siffert, Winfried ^a   Haag, Sebastian ^a   Mueller, Norbert ^a   Langkafel, Mathias ^a   Senf, Wolfgang ^a   Zotz, Rainer ^b   Talley, Nicholas J ^c  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^c MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN BETA3; PROTEIN SUBUNIT; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSPEPSIA; FEMALE; GASTROINTESTINAL DISEASE; GASTROINTESTINAL SYMPTOM; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 1842583755     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2004.01.006     Document Type: Article

References (54)

1. Thompson WG, Longstreth GF, Drossman DA, Heaton KW, Irvine EJ, Muller-Lissner SA. Functional bowel disorders and functional abdominal pain. Gut 1999;45(Suppl 2):1143-1147.
2. Locke GR III. The epidemiology of functional gastrointestinal disorders in North America. Gastroenterol Clin North Am 1996;25: 1-19.
3. Stanghellini V, Tosetti C, Paternico A, Barbara G, Morselli Labate AM, Monetti N, Marengo M, Corinaldesi R. Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia. Gastroenterology 1996;110:1036-1042.
4. Tack J, Piessevaux H, Coulie B, Caenepeel P, Janssens J. Role of impaired gastric accommodation to a meal in functional dyspepsia. Gastroenterology 1998;115:1346-1352.
5. Holtmann G, Goebell H, Jockenhövel F, Talley NJ. Altered vagal and intestinal mechano-sensory function in chronic unexplained dyspepsia. Gut 1998;42:501-506.
6. Coffin B, Azpiroz F, Malagelada JR. Selective gastric hypersensitivity and reflex hyporeactivity in functional dyspepsia. Gastroenterology 1991;100:A431.
7. Drossman DA, McKee DC, Sandler RS, Mitchell GM, Cramer EM, Lowman BC, Burger AL. Psychological factors in the irritable bowel syndrome. A multivariate study of patients and nonpatients with irritable bowel syndrome. Gastroenterology 1988;95:701-708.
8. Drossman DA. Personality and psychosocial factors in the irritable bowel syndrome. Gastroenterol Clin Biol 1990;14:49C-53C.
9. Addolorato G, Marsigli L, Capristo E, Caputo F, Dall'Aglio C, Baudanza P. Anxiety and depression: a common feature of health care seeking patients with irritable bowel syndrome and food allergy. Hepatogastroenterology 1998;45:1559-1564.
10. Holtmann G, Talley NJ, Mitchell H, Hazell S. Antibody response to specific H. pylori antigens in functional dyspepsia, duodenal ulcer disease, and health. Am J Gastoenterol 1998;93:1222-1227.
11. McKendrick MW, Read NW. Irritable bowel syndrome-post salmonella infection. J Infect 1994;29:1-3.
12. Tack J, Demedts I, Dehondt G, Caeepeel P, Fischler B, Zandecki M, Janssens J. Clinical and pathophysiologic characteristics of acute-onset functional dyspepsia. Gastroenterology 2002;122: 1738-1747.
13. Locke GR III, Zinsmeister AR, Talley NJ, Fett SL, Melton LJ III. Familial association in adults with functional gastrointestinal disorders. Mayo Clin Proc 2000;75:907-912.
14. Levy RL, Jones KR, Whitehead WE, Feld SI, Talley NJ, Corey LA. Irritable bowel syndrome in twins: heredity and social learning both contribute to etiology. Gastroenterology 2001;121:799-804.
15. Morris-Yates A, Talley NJ, Boyce PM, Nandurkar S, Andrews G. Evidence of a genetic contribution to functional bowel disorder. Am J Gastroenterol 1998;93:1311-1317.
16. Kellow JE, Miller LJ, Phillips SF, Zinsmeister AR, Charboneau JW. Altered sensitivity of the gallbladder to cholecystokinin octapeptide in irritable bowel syndrome. Am J Physiol 1987;253:G650-G655.
17. Chua A, Keating J, Hamilton D, Keeling PW, Dinan TG. Central serotonin receptors and delayed gastric emptying in non-ulcer dyspepsia. BMJ 1992;305:280-282.
18. Dinan TG, Barry S, Ahkion S, Chua A, Keeling PWN. Assessment of central noradrenergic functioning in irritable bowel syndrome using a neuroendocrine challenge test. J Psychosom Res 1990; 34:575-580.
19. Bharucha AE, Camilleri M, Zinsmeister AR, Hanson RB. Adrenergic modulation of human colonic motor and sensory function. Am J Physiol 1997;273:G997-G1006.
20. Gollasch M, Kleuss C, Hescheler J, Wittig B, Schultz G. Gi2 and protein kinase C are required for thyrotropin-releasing hormone-induced stimulation of voltage-dependent Ca2+ channels in rat pituitary GH3 cells. Proc Natl Acad Sci U S A 1993;90:6265-6269.
21. Kleuss C, Hescheler J, Ewel C, Rosenthal W, Schultz G, Wittig B. Assignment of G-protein subtypes to specific receptors inducing inhibition of calcium currents. Nature 1991;353:43-48.
22. Kleuss C, Scherubl H, Hescheler J, Schultz G, Wittig B. Different beta-subunits determine G-protein interaction with transmembrane receptors. Nature 1992;358:424-426.
23. Kleuss C, Scherubl H, Hescheler J, Schultz G, Wittig B. Selectivity in signal transduction determined by gamma subunits of heterotrimeric G proteins. Science 1993;259:832-834.
24. Baumgart D, Naber C, Haude M, Oldenburg O, Erbel R, Heusch G, Siffert W. G protein beta3 subunit 825T allele and enhanced coronary vasoconstriction on alpha(2)-adrenoceptor activation. Circ Res 1999;85:965-969.
25. Zill P, Baghai TC, Zwanzger P, Schule C, Minov C, Riedel M, Neumeier K, Rupprecht R, Bondy B. Evidence for an association between a G-protein beta3-gene variant with depression and response to antidepressant treatment. Neuroreport 2000;11: 1893-1897.
26. Lindemann M, Virchow S, Ramann F, Barsegian V, Kreuzfelder E, Siffert W, Muller N, Grosse-Wilde H. The G protein beta3 subunit 825T allele is a genetic marker for enhanced T cell response. FEBS Lett 2001;495:82-86.
27. Holtmann G, Gschossmann J, Neufang-Huber J, Gerken G, Talley NJ. Differences in gastric mechanosensory function after repeated ramp distensions in non-consulters with dyspepsia and healthy controls. Gut 2000;47:332-336.
28. Holtmann G, Goebell H, Holtmann M, Talley NJ. Dyspepsia in healthy blood donors: pattern of symptoms and association with Helicobacter pylori. Dig Dis Sci 1994;39:1090-1098.
29. Talley NJ, Phillips SF, Melton LJI, Wiltgen C, Zinsmeister AR. A patient questionnaire to identify bowel disease. Ann Intern Med 1989;111:671-674.
30. Holtmann G, Goebell H, Talley NJ. Dyspepsia in consulters and non-consulters: prevalence, health-care seeking behaviour and risk factors. Eur J Gastroenterol Hepatol 1994;6:917-924.
31. Locke GR, Talley NJ, Weaver AL, Zinsmeister AR. The fluctuating course of functional bowel disease: a four-year community study. Gastroenterology 1994;106:A16.
32. Talley NJ, Zinsmeister AR, Schleck CD, Melton LJI, Melton U. Smoking, alcohol and analgesics in dyspepsia and among dyspepsia subgroups: lack of an association in the community. Gut 1994;35:619-624.
33. Talley NJ, Zinsmeister AR, Schleck CD, Melton LJI. Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology 1992;102:1259-1268.
34. Herrmann C. International experiences with the Hospital Anxiety and Depression Scale: a review of validation data and clinical results. J Psychosom Res 1997;42:17-41.
35. Sigmond AS, Snaith RS. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983;67:361-370.
36. Talley NJ, Colin-Jones D, Koch KL, Koch M, Nyrén O, Stanghellini V. Functional dyspepsia: a classification with guidelines for diagnosis and management. Gastroenterol Int 1991;4:145-160.
37. Talley NJ, Stanghellini V, Heading RC, Koch KL, Malagelada JR, Tytgat GN. Functional gastroduodenal disorders. Gut 1999; 45(Suppl 2):1137-1142.
38. Siffert W, Rosskopf D, Siffert G, Busch S, Moritz A, Erbel R, Sharma AM, Ritz E, Wichmann HE, Jakobs KH, Horsthemke B. Association of a human G-protein beta3 subunit variant with hypertension. Nat Genet 1998;18:45-48.
39. Gardner M, Altman DG. Calculating confidence intervals for proportions and their differences. In: Gardner M, Altman DG, eds. Statistics with confidence-confidence intervals and statistical guidelines. London: BMJ 1989:28-33.
40. Fleiss JL. Statistical methods for rates and proportions. 2nd ed. Chichester: Wiley, 1982:;56-82.
41. Rogatko A, Slifker MJ, Babb JS. Hardy-Weinberg equilibrium diagnostics. Theor Popul Biol 2002;62:251-257.
42. SAS Institute Inc. SAS/STAT software: changes and enhancements through release 6.12, Cary, NC: SAS Institute, 1997.
43. SAS Institute Inc. SAS/STAT user guide. Volumes 1 and 2. 4th ed. Cary, NC: SAS Institute, Inc, 1990.
44. Wilmer A, Van Cutsem E, Andrioli T, Tack J, Coremans G, Janssens J. Ambulatory gastro-jejunal manometry in severe motility-like dyspepsia: lack of correlation between dysmotility, symptoms, and gastric emptying. Gut 1999;42:235-242.
45. Greydanus MP, Vassallo M, Camilleri M, Nelson DK, Hanson RB, Thomforde GM. Neurohormonal factors in functional dyspepsia: insights on pathophysiological mechanisms. Gastroenterology 1991;100:1311-1318.
46. Exton MS, Artz M, Siffert W, Schedlowski M. G protein beta3 subunit 825T allele is associated with depression in young, healthy subjects. Neuroreport 2003;14:531-533.
47. Siffert W, Forster P, Jockel KH, Mvere DA, Brinkmann B, Naber C, Crookes R, Du PH, Epplen JT, Fridey J, Freedman BI, Muller N, Stolke D, Sharma AM, Al Moutaery K, Grosse-Wilde H, Buerbaum B, Ehrlich T, Ahmad HR, Horsthemke B, Du Toit ED, Tiilikainen A, Ge J, Wang Y, Rosskopf D. Worldwide ethnic distribution of the G protein beta3 subunit 825T allele and its association with obesity in Caucasian, Chinese, and Black African individuals. J Am Soc Nephrol 1999;10:1921-1930.
48. Drossman DA, Li Z, Andruzzi E, Temple RD, Talley NJ, Thompson WG, Whitehead WE, Janssens J, Funch Jensen P, Corazziari E, Richter JE, Koch GG. U.S. Householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci 1993;38:1569-1580.
49. Locke GR, Talley NJ, Weaver AL, Zinsmeister AR. Risk factors for functional bowel disease and health care seeking: a population-based case-control study. Gastroenterology 1994;106:A15.
50. Lin CN, Tsai SJ, Hong CJ. Association analysis of a functional G protein beta 3 subunit gene polymorphism (C825T) in mood disorders. Neuropsychobiology 2001;44:118-121.
51. Turner ST, Schwartz GL, Chapman AB, Boerwinkle E. C825T polymorphism of the G protein beta(3)-subunit and antihypertensive response to a thiazide diuretic. Hypertension 2001;37:739-743.
52. Sperber AD, Rotem AY, Fich A, Roitman G, Schreiber G, Avissar S. G protein levels and function as an objective measure of depression in patients with functional bowel disorders. Int J Colorectal Dis 2000;15:218-224.
53. Evans PR, Dowsett JF, Bak YT, Chan Y, Kellow JE. Abnormal sphincter of Oddi response to cholecystokinin in postcholecystectomy syndrome patients with irritable bowel syndrome: the irritable sphincter. Dig Dis Sci 1995;40:1149-1156.
54. Dinan TG, Yatham LN, Barry S, Chua A, Keeling PWN. Serotonin supersensitivity: the pathophysiologic basis of non-ulcer dyspepsia. Scand J Gastroenterol 1990;25:541-544.